Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The present study aims to investigate whether the dosage of the GnRH agonist used for
triggering final oocyte maturation affects the maturity of the oocytes retrieved in high risk
for OHSS patients undergoing ovarian stimulation for IVF using GnRH antagonists and
recombinant FSH.